Investors

Tiziana Life Sciences LTD (“Company”) is a biotechnology company that focuses on the discovery and development of novel molecules that treat human disease in oncology and immunology.

Investors

Press Releases

Nov 23 2022

Tiziana Announces Publication of a Peer-Reviewed Article on the Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function and an Induced T Cell Regulatory Response in Human Subjects

Nov 10 2022

Tiziana Life Sciences Announces Near-Term Strategic Focus on Intranasal Foralumab for Diseases of the Central Nervous System (CNS)

Nov 04 2022

Tiziana Life Sciences to Host Investor Call

btn News

View All

Events & Presentations

Nov 10 2022 at 10:00 AM EST

Investor call

Jun 14 2022 at 2:00 PM PDT

Tiziana Life Sciences to Present at the 2022 Biotechnology Innovation Organization Annual Convention

Apr 27 2022 at 2:30 PM EDT

Tiziana Life Sciences to Present at the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference

btn Events

View All

Interim Reports

Interim Results for the Six Months Ended 30 June 2021 563.4 KB

bth Interim Reports

View All

Annual Reports

20 F - Annual Report for the year ended 31 December 2021 1.9 MB

btn ARs

View All

Annual General Meeting

Results of General Meeting September 2021 129.9 KB

btn AGM

View All

Scientific Pipeline Progress

Learn more

Stock Quote

Change

Volume

Today's Open

Previous Close

Today's High

Today's Low

52 Week High

52 Week Low

Stock Chart

Email Alerts

Price
Change
Price
Change

Alert type
Quote
SEC Filing
Event
News
Weekly Summary

IR Nav

Investors

btn Profile

Investors

btn News

btn Events

bth Interim Reports

btn ARs

btn AGM

Scientific Pipeline Progress

Stock Quote

Stock Chart

Email Alerts